Literature DB >> 25998900

Type 2 diabetes as a protein misfolding disease.

Abhisek Mukherjee1, Diego Morales-Scheihing2, Peter C Butler3, Claudio Soto4.   

Abstract

Type 2 diabetes (T2D) is a highly prevalent and chronic metabolic disorder. Recent evidence suggests that formation of toxic aggregates of the islet amyloid polypeptide (IAPP) might contribute to β-cell dysfunction and disease. However, the mechanism of protein aggregation and associated toxicity remains unclear. Misfolding, aggregation, and accumulation of diverse proteins in various organs is the hallmark of the group of protein misfolding disorders (PMDs), including highly prevalent illnesses affecting the central nervous system (CNS) such as Alzheimer's disease (AD) and Parkinson's disease (PD). In this review we discuss the current understanding of the mechanisms implicated in the formation of protein aggregates in the endocrine pancreas and associated toxicity in the light of the long-standing knowledge from neurodegenerative disorders associated with protein misfolding.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  amyloid; islet amyloid polypeptide; prions; protein misfolding; type 2 diabetes; β cells

Mesh:

Substances:

Year:  2015        PMID: 25998900      PMCID: PMC4492843          DOI: 10.1016/j.molmed.2015.04.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  159 in total

1.  Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells.

Authors:  Lucy Marzban; Galina Soukhatcheva; C Bruce Verchere
Journal:  Endocrinology       Date:  2004-12-23       Impact factor: 4.736

Review 2.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

3.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

Review 4.  Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

Authors:  Steven E Kahn; Mark E Cooper; Stefano Del Prato
Journal:  Lancet       Date:  2013-12-03       Impact factor: 79.321

5.  Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion.

Authors:  Ann-Hwee Lee; Keely Heidtman; Gökhan S Hotamisligil; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

6.  Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.

Authors:  Emma T A S Jaikaran; Melanie R Nilsson; Anne Clark
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

7.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

Review 8.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Authors:  Charles G Glabe
Journal:  Neurobiol Aging       Date:  2006-02-14       Impact factor: 4.673

9.  Disease-associated prion protein oligomers inhibit the 26S proteasome.

Authors:  Mark Kristiansen; Pelagia Deriziotis; Derek E Dimcheff; Graham S Jackson; Huib Ovaa; Heike Naumann; Anthony R Clarke; Fijs W B van Leeuwen; Victoria Menéndez-Benito; Nico P Dantuma; John L Portis; John Collinge; Sarah J Tabrizi
Journal:  Mol Cell       Date:  2007-04-27       Impact factor: 17.970

10.  p62/SQSTM1-dependent autophagy of Lewy body-like α-synuclein inclusions.

Authors:  Yoshihisa Watanabe; Harutsugu Tatebe; Katsutoshi Taguchi; Yasuhisa Endo; Takahiko Tokuda; Toshiki Mizuno; Masanori Nakagawa; Masaki Tanaka
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  86 in total

Review 1.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

Review 2.  Prion-Like Protein Aggregates and Type 2 Diabetes.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

Review 3.  Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.

Authors:  Wei-Jen Tang
Journal:  Trends Endocrinol Metab       Date:  2015-12-02       Impact factor: 12.015

4.  Cells Deploy a Two-Pronged Strategy to Rectify Misfolded Proinsulin Aggregates.

Authors:  Corey N Cunningham; Jeffrey M Williams; Jeffrey Knupp; Anoop Arunagiri; Peter Arvan; Billy Tsai
Journal:  Mol Cell       Date:  2019-06-05       Impact factor: 17.970

5.  Helix Dipole and Membrane Electrostatics Delineate Conformational Transitions in the Self-Assembly of Amyloidogenic Peptides.

Authors:  Qiuchen Zheng; Senegal N Carty; Noel D Lazo
Journal:  Langmuir       Date:  2020-07-15       Impact factor: 3.882

6.  The Cdc48 Complex Alleviates the Cytotoxicity of Misfolded Proteins by Regulating Ubiquitin Homeostasis.

Authors:  Ryan Higgins; Marie-Helene Kabbaj; Delaney Sherwin; Lauren A Howell; Alexa Hatcher; Robert J Tomko; Yanchang Wang
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

7.  BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression.

Authors:  Gema Alcarraz-Vizán; Carlos Castaño; Montse Visa; Joel Montane; Joan-Marc Servitja; Anna Novials
Journal:  Cell Mol Life Sci       Date:  2017-03-23       Impact factor: 9.261

8.  Role of domain interactions in the aggregation of full-length immunoglobulin light chains.

Authors:  Enrico Rennella; Gareth J Morgan; Jeffery W Kelly; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-31       Impact factor: 11.205

9.  Translocon Declogger Ste24 Protects against IAPP Oligomer-Induced Proteotoxicity.

Authors:  Can Kayatekin; Audra Amasino; Giorgio Gaglia; Jason Flannick; Julia M Bonner; Saranna Fanning; Priyanka Narayan; M Inmaculada Barrasa; David Pincus; Dirk Landgraf; Justin Nelson; William R Hesse; Michael Costanzo; Chad L Myers; Charles Boone; Jose C Florez; Susan Lindquist
Journal:  Cell       Date:  2018-03-08       Impact factor: 41.582

Review 10.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.